ADC Therapeutics
ADCT
#9439
Rank
$0.14 B
Marketcap
$1.13
Share price
4.63%
Change (1 day)
-72.30%
Change (1 year)

Earnings for ADC Therapeutics (ADCT)

Earnings in 2026 (TTM): -$45.05 Million USD

According to ADC Therapeutics's latest financial reports the company's current earnings are $79.58 Million USD. In 2025 the company made an earning of -$89.98 Million USD, an increase over its 2024 earnings that were of -$0.11 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ADC Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$45.05 Million-49.93%
2025 -$89.98 Million-15.06%
2024 -$0.11 Billion-28.7%
2023 -$0.15 Billion26.19%
2022 -$0.12 Billion-49.5%
2021 -$0.24 Billion-3.27%
2020 -$0.25 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-$0.16 Billion 246.59%๐Ÿ‡บ๐Ÿ‡ธ USA